BLTE (Belite Bio) Interest Expense : $0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Belite Bio Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Belite Bio's interest expense for the three months ended in Jun. 2024 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Belite Bio's Operating Income for the three months ended in Jun. 2024 was $ -10.47 Mil. Belite Bio's Interest Expense for the three months ended in Jun. 2024 was $ 0.00 Mil. Belite Bio has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Belite Bio Interest Expense Historical Data

The historical data trend for Belite Bio's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belite Bio Interest Expense Chart

Belite Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Interest Expense

-0.02

-0.03

Belite Bio Quarterly Data
	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Interest Expense	Get a 7-Day Free Trial								-	-	-	-	-

Belite Bio Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Belite Bio (NAS:BLTE) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Belite Bio's Interest Expense for the three months ended in Jun. 2024 was $0.00 Mil. Its Operating Income for the three months ended in Jun. 2024 was $-10.47 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2024 was $0.00 Mil.

Belite Bio's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Belite Bio had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Belite Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Belite Bio Inc (NAS:BLTE) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

D01:Germany

Address

12750 High Bluff Drive, Suite 475, San Diego, CA, USA, 92130

Website

https://www.belitebio.com

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.